A patient with myelofibrosis complicated by refractory ascites and portal hypertension: To tips or not to tips? A case report with discussion of the mechanism of ascites formation

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 4, 2004, Pages 389-394

  Wiest, R ^a   Strauch, U ^a   Wagner, H ^a   Strotzer, M ^a   Woenckhaus, M ^a   Schroder G ^a   Scholmerich J ^a   Lock, G ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Ascites; Myelofibrosis; Portal hypertension; Portosystemic shunt

Indexed keywords

DIURETIC AGENT; PROTEIN;

AGED; ARTICLE; ASCITES; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; MEDICAL EXAMINATION; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; ONCOTIC PRESSURE; PARACENTESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SODIUM RESTRICTION; TREATMENT OUTCOME;

AGED; ASCITES; HUMANS; HYPERTENSION, PORTAL; MALE; MYELOFIBROSIS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 1942421323     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310007521     Document Type: Article

References (31)

1. Toni R, Bolondi L, Gaiani S, Re G, Calabrese L, Cavalli G, et al. Accessory ultrasonographic findings in chronic liver disease: diameter of splenic and hepatic arteries, fasting gallbladder volume, and course of left portal vein. J Clin Ultrasound 1985;13: 611-8.
2. Cirera I, Elizalde JI, Pique JM, Feu F, Casadevall M, Goldin E, et al. Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. Dig Dis Sci 1997;42:1697-702.
3. Lee WC, Lin HC, Hou MC, Lee FY, Chang FY, Tsai YT, et al. Effect of anaemia on haemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 1999;14:370-5.
4. Heuck G. Zwei Fälle von Leukämie mit eigentümlichem Blut resp. Knochenmarksbefund. Virchows Arch 1879;78:475-96.
5. Beckman EN, Oehrle JS. Fibrous hematopoietic tumors arising in agnogenic myeloid metaplasia. Hum Pathol 1982;13:804-10.
6. Linman JW, Bethell FH. Agnogenic myeloid metaplasia. Am J Med 1957;22:107-22.
7. Pitcock JA, Reinhard EH, Justus BW, Mendelsohn RS. A clinical and pathological study of seventy cases of myelofibrosis. Ann Intern Med 1962;57:73-84.
8. Silverman JF. Extramedullary hematopoietic ascitic fluid cytology in myelofibrosis. Am J Clin Pathol 1985;84:125-8.
9. Nakai GS, Craddock CG, Figuero WG. Agnogenic myeloid metaplasia: a survey of twenty-nine cases and a review of the literature. Ann Intern Med 1962;57:419-40.
10. Silverstein MN, Wollaeger EE, Baggenstoss AH. Gastrointestinal and abdominal manifestations of agnogenic myeloid metaplasia. Arch Intern Med 1973;131:532-7.
11. Ward HP, Block MH. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine (Baltimore) 1971;50:357-420.
12. Shaldon S, Sherlock S. Portal hypertension in the myeloproliferative syndrome and the reticuloses. Am J Med 1962;32:758-64.
13. Blendis LM, Banks DC, Ramboer C, Williams R. Spleen blood flow and splanchnic haemodynamics in blood dyscrasia and other splenomegalies. Clin Sci 1970;38:73-84.
14. Oishi M, Swisher SN, Stormont JM, Schwartz SI. Portal hypertension in myeloid metaplasia. Arch Surg 1960. p. 81[80].
15. Rosenbaum DL, Murphy GW, Swisher SN. Hemodynamic studies of the portal circulation in myeloid metaplasia. Am J Med 1966;41:360-8.
16. Cassel WG, Spittel JA, Ellis FH. Arteriovenous fistula of the splenic vessels producing ascites. Circulation 1957;16:1077-83.
17. Stone HH, Jordan WD, Acker JJ. Portal arteriovenous fistula: review and case report. Am J Surg 1965;109:191-6.
18. Leevy CM, Mendenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. J Clin Invest 1962; 41:1169-79.
19. Siniluoto TM, Hyvarinen SA, Paivansalo MJ, Alavaikko MJ, Suramo IJ. Abdominal ultrasonography in myelofibrosis. Acta Radiol 1992;33:343-6.
20. Belohlavek J, Schwarz J, Jirasek A, Krajina A, Polak F, Hruby M. Idiopathic myelofibrosis complicated by portal hypertension treated with a transjugular intrahepatic portosystemic shunt (TIPS). Wien Klin Wochenschr 2001;113:208-11.
21. Lafortune M, Martinet JP, Denys A, Patriquin H, Dauzat M, Colombato L, et al. Short-and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study. Am J Roentgenol 1995;164:997-1002.
22. Tanaka N, Yamakado K, Kihira H, Hashimoto A, Murayama T, Takeda K. Transjugular intrahepatic portosystemic shunt for intractable esophageal hemorrhage in a patient with idiopathic myelofibrosis. Cardiovasc Intervent Radiol 2000;23:491-2.
23. Rössle M, Ochs A, Gülberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-7.
24. Marshall JB, Burnett DA, Anderson JC, Zetterman RK. Ascites progressing to an abdominal mass due to extramedullary hematopoiesis in a patient with agnogenic myeloid metaplasia (AMM). Dig Dis Sci 1983;28:912-7.
25. Liote F, Yeni P, Teillet-Thiebaud F, Barge J, Devars Du Mayne JF, Flamant Y, et al. Ascites revealing peritoneal and hepatic extramedullary hematopoiesis with peliosis in agnogenic myeloid metaplasia: case report and review of the literature. Am J Med 1991;90:111-7.
26. Gorshein D, Brauer MJ. Ascites in myeloid metaplasia due to ectopic peritoneal implantations. Cancer 1969;23:1408-12.
27. Hung SC, Huang ML, Liu SM, Hsu HC. Massive ascites caused by peritoneal extramedullary hematopoesis as the initial manifestation of myelofibrosis. Am J Med Sci 1999;318:198-200.
28. Yatsumoto M, Ishida F, Ito T, Ueno M, Kitano K, Kiyosawa K. Idiopathic myelofibrosis with refractory massive ascites. Intern Med 2003;42:525-8.
29. Calle S. Megakaryocytes in an abdominal fluid. Acta Cytol 1968; 12:78-80.
30. Kumar NB, Naylor B. Megakaryocytes in pleural and peritoneal fluids: prevalence, significance, morphology, and cytohistological correlation. J Clin Pathol 1980;33:1153-9.
31. Silverman JF. Extramedullary hematopoietic ascitic fluid cytology in myelofibrosis. Am J Clin Pathol 1985;84:125-8.